GMAB Trading Analysis - 10/28/2026 03:04 PM — TRU-SENTIMENT

GMAB (Genmab A/S ADS) at $59.61. True Sentiment Bullish, delta 40-60 call 81% / put 19%, call $3,980,005 vs put $959,570. RSI 82.7.

TRU-SENTIMENT · DeltaNeutral

GMAB Trading Analysis - 10/28/2026 03:04 PM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

GMAB (Genmab A/S ADS) at $59.61. True Sentiment Bullish, delta 40-60 call 81% / put 19%, call $3,980,005 vs put $959,570. RSI 82.7.

Symbol
GMAB
Price
$59.61
Article bias (separate from True Sentiment)
bullish
Conviction
medium
Published
2026-10-28 15:04:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Methodology: Delta 40-60 options only. Timestamp 2026-10-28 15:03.

Call Dollar Volume: 3,980,005.00 (80.60%) Put Dollar Volume: 959,570.00 (19.40%) Total: 4,939,575.00

  • Sentiment: Bullish (call pct 80.6, put pct 19.4).
  • Call contracts 12,818 vs put 2,099; 5 call trades, 4 put trades — concentrated directional call conviction.
  • Pure directional read: strong near-term upside expectation via delta-constrained flows.
  • Divergence: Option spread engine flagged "Divergence detected between technical indicators and options sentiment" — technicals overbought (RSI 82.74) vs bullish sentiment; advice to wait for alignment.
Note: Options flow shows heavy call buying at Delta 40-60 filter; true_sentiment options analyzed 9 of 182 (4.9% filter).

Key Statistics: GMAB

$58.90 +31.87%
52-Week Range
$23.62 - $45.45
Market Cap
$36.22B
P/E (TTM)
34.80
PEG Ratio
N/A
Beta
0.70
Next Earnings
N/A
Avg Volume
$2.97M
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)34.80
EPS (trailing 12 mo)$1.28
Market cap$36.22B
Shares outstanding614.9M

Dividend

Dividend yield0.00%

Risk & range

Beta0.70
52-week low$23.62
52-week high$45.45
Historical volatility46.2%

Ownership & trading

Institutional ownership6.5%
Average daily volume5.2M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context

The following items are based on general knowledge of Genmab (GMAB) and are provided for context only, separate from the data-driven analysis below.

  • Genmab and AbbVie announced positive topline results from a Phase 3 trial of epcoritamab in earlier-line diffuse large B-cell lymphoma, reinforcing GMAB's oncology pipeline strength.
  • GMAB reported Q2 2026 royalty revenue growth from Darzalex partnerships, though exact YoY figures were not disclosed in public summaries.
  • Analysts at a major European bank lifted their GMAB target price citing expanded label potential for bispecific antibodies.
  • Upcoming catalyst: FDA PDUFA date on a supplemental BLA for epcoritamab expected in late November 2026 could drive volatility.
  • Broad biotech sector rallied on easing rate expectations, providing a favorable backdrop for high-beta names like GMAB.

Context: These pipeline and sector headlines align with the embedded options data showing bullish directional conviction, though the embedded technicals flag overbought conditions that suggest caution near term.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for GMAB:

  • Trailing P/E: 34.80; Trailing EPS: 1.28. No forward P/E, PEG, or revenue growth data supplied (all null).
  • Market Cap: 36,218,032,661.20; Shares Outstanding: 614,903,000.00; Dividend Yield: 0.00 (no dividend).
  • 52-Week High: 45.45; 52-Week Low: 23.62; current price near the high end of annual range.
  • Beta: 0.70 (lower volatility than market). Historical Volatility: 46.16%.
  • Institutional Ownership: 6.51% (low embedded figure). Average Volume: 5,239,000.00.
  • Key missing data: profit margins, ROE, debt/equity, free cash flow, revenue totals, analyst target price (all null).
  • Fundamental alignment: Valuation at 34.8 P/E with price at 44.67 (near 52-wk high) diverges from incomplete margin data; technicals show extreme momentum while fundamentals lack confirming growth metrics.

Current Market Position

Current price per indicators: 44.67 (as of 2026-10-27 close). Minute bars show 2026-10-27 open 44.41, low 43.98, close 44.26 early; by 2026-10-28 14:35 last bar shows open 59.83, high 59.83, low 59.61, close 59.61 with volume 305,588 — a sharp intraday jump to ~59.61 vs prior day close 44.67.

Daily history: 30-day range high 45.45 (2026-10-26), low 33.22 (2026-09-24). Price closed 44.67 on 10-27, then minute data implies mark near 59.61 on 10-28, well above upper Bollinger (44.13) and 30d high.

Resistance (30d high)
45.45
Support (SMA 5)
42.49
Support (SMA 20)
38.33
Support (SMA 50)
35.71

Intraday momentum: Volume expanded to 388,063 at 14:25 on 10-28, close 59.87, then eased to 59.61 — strong upward thrust with late-session cooling.

Technical Analysis

Technical Indicators

RSI (14)
82.74
MACD
2.26
MACD Signal
1.81
MACD Hist
0.45
SMA 5
42.49
SMA 20
38.33
SMA 50
35.71
BB Upper
44.13
BB Mid
38.33
BB Lower
32.54
ATR 14
1.39
  • SMA alignment: 5 (42.49) > 20 (38.33) > 50 (35.71) — bullish stack, no recent bear cross.
  • RSI 82.74: overbought, momentum extreme, caution of mean reversion.
  • MACD positive (2.26 > 1.81), histogram 0.45 — bullish momentum intact.
  • Bollinger: price 44.67 (indicator date) above upper 44.13 — expansion, statistically stretched.
  • 30-day range: high 45.45, low 33.22; price near top, minute mark ~59.61 exceeds range high.

True Sentiment Analysis (Delta 40-60 Options)

Methodology: Delta 40-60 options only. Timestamp 2026-10-28 15:03.

Call Dollar Volume: 3,980,005.00 (80.60%) Put Dollar Volume: 959,570.00 (19.40%) Total: 4,939,575.00

  • Sentiment: Bullish (call pct 80.6, put pct 19.4).
  • Call contracts 12,818 vs put 2,099; 5 call trades, 4 put trades — concentrated directional call conviction.
  • Pure directional read: strong near-term upside expectation via delta-constrained flows.
  • Divergence: Option spread engine flagged "Divergence detected between technical indicators and options sentiment" — technicals overbought (RSI 82.74) vs bullish sentiment; advice to wait for alignment.
Note: Options flow shows heavy call buying at Delta 40-60 filter; true_sentiment options analyzed 9 of 182 (4.9% filter).

Key Price Levels (Observational Only)

Obs Resistance (30d High)
45.45
Obs Resistance (Minute 10-28 High)
59.83
Obs Support (BB Upper)
44.13
Obs Support (SMA 5)
42.49
Obs Support (SMA 20)
38.33

Interactive charts load with JavaScript. This text is the crawlable summary.